These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 15126106

  • 21. Treatment and prevention of experimental autoimmune myocarditis with CD28 superagonists.
    Wang S, Liu J, Wang M, Zhang J, Wang Z.
    Cardiology; 2010; 115(2):107-13. PubMed ID: 19907173
    [Abstract] [Full Text] [Related]

  • 22. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines.
    Futamatsu H, Suzuki J, Mizuno S, Koga N, Adachi S, Kosuge H, Maejima Y, Hirao K, Nakamura T, Isobe M.
    Circ Res; 2005 Apr 29; 96(8):823-30. PubMed ID: 15774858
    [Abstract] [Full Text] [Related]

  • 23. [Effects of matrix metalloproteinase-9 inhibitor in Lewis rats with experimental autoimmune myocarditis].
    Han LN, Li TL, Zhang YJ, Yang TS, Ding Y, Zhao XN, Guo SL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb 29; 39(2):118-23. PubMed ID: 21426744
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis.
    Matsui Y, Okamoto H, Jia N, Akino M, Uede T, Kitabatake A, Nishihira J.
    J Mol Cell Cardiol; 2004 Aug 29; 37(2):557-66. PubMed ID: 15276025
    [Abstract] [Full Text] [Related]

  • 26. Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress.
    Sukumaran V, Watanabe K, Veeraveedu PT, Ma M, Gurusamy N, Rajavel V, Suzuki K, Yamaguchi K, Kodama M, Aizawa Y.
    Eur J Pharmacol; 2011 Feb 10; 652(1-3):126-35. PubMed ID: 21115000
    [Abstract] [Full Text] [Related]

  • 27. Whole-body hyperthermia attenuates experimental autoimmune myocarditis in the rat.
    Barsheshet A, Barshack I, Keren P, Keren G, George J.
    Cardiovasc Pathol; 2008 Feb 10; 17(6):375-81. PubMed ID: 18402844
    [Abstract] [Full Text] [Related]

  • 28. Pathogenesis of myocarditis and dilated cardiomyopathy.
    Cihakova D, Rose NR.
    Adv Immunol; 2008 Feb 10; 99():95-114. PubMed ID: 19117533
    [Abstract] [Full Text] [Related]

  • 29. Immunoregulatory effects of α-GalCer in a murine model of autoimmune myocarditis.
    Liu W, Li S, Tian W, Li W, Zhang Z.
    Exp Mol Pathol; 2011 Oct 10; 91(2):636-42. PubMed ID: 21791205
    [Abstract] [Full Text] [Related]

  • 30. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
    Liu W, Feng W, Wang F, Li W, Gao C, Zhou B, Ma M.
    Exp Mol Pathol; 2008 Jun 10; 84(3):213-7. PubMed ID: 18417124
    [Abstract] [Full Text] [Related]

  • 31. A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivation.
    Futamatsu H, Suzuki J, Koga N, Adachi S, Kosuge H, Maejima Y, Haga T, Hirao K, Horuk R, Isobe M.
    J Mol Cell Cardiol; 2006 Jun 10; 40(6):853-61. PubMed ID: 16698032
    [Abstract] [Full Text] [Related]

  • 32. Sulfated polysaccharide fucoidan ameliorates experimental autoimmune myocarditis in rats.
    Tanaka K, Ito M, Kodama M, Tomita M, Kimura S, Hoyano M, Mitsuma W, Hirono S, Hanawa H, Aizawa Y.
    J Cardiovasc Pharmacol Ther; 2011 Mar 10; 16(1):79-86. PubMed ID: 21193680
    [Abstract] [Full Text] [Related]

  • 33. Chronic myocarditis induced by T cells reactive to a single cardiac myosin peptide: persistent inflammation, cardiac dilatation, myocardial scarring and continuous myocyte apoptosis.
    Ratcliffe NR, Hutchins J, Barry B, Hickey WF.
    J Autoimmun; 2000 Nov 10; 15(3):359-67. PubMed ID: 11040076
    [Abstract] [Full Text] [Related]

  • 34. Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis.
    Nishii M, Inomata T, Niwano H, Takehana H, Takeuchi I, Nakano H, Shinagawa H, Naruke T, Koitabashi T, Nakahata J, Izumi T.
    Circulation; 2006 Aug 29; 114(9):936-44. PubMed ID: 16908771
    [Abstract] [Full Text] [Related]

  • 35. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. The utility of a class II binding motif in selecting self-reactive peptides.
    Wegmann KW, Zhao W, Griffin AC, Hickey WF.
    J Immunol; 1994 Jul 15; 153(2):892-900. PubMed ID: 8021520
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Peroxisome proliferation-activated receptor-gamma ligands ameliorate autoimmune myocarditis associated with inhibition of T cell immunity].
    Yuan ZY, Liu Y, Liu Y, Zhang JJ, Kishimoto C, Liu ZQ.
    Zhonghua Yi Xue Za Zhi; 2003 Dec 10; 83(23):2067-72. PubMed ID: 14703419
    [Abstract] [Full Text] [Related]

  • 38. Autoimmune myocarditis.
    Smith SC.
    Curr Protoc Immunol; 2001 May 10; Chapter 15():Unit 15.14. PubMed ID: 18432731
    [Abstract] [Full Text] [Related]

  • 39. The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis.
    Shimazaki H, Watanabe K, Veeraveedu PT, Harima M, Thandavarayan RA, Arozal W, Tachikawa H, Kodama M, Aizawa Y.
    Free Radic Res; 2010 Sep 10; 44(9):1082-90. PubMed ID: 20815771
    [Abstract] [Full Text] [Related]

  • 40. [Intervention effect of PI3Kgamma inhibitor AS605240 on autoimmune myocarditis in mice].
    Jin K, Song LF, He CM, Wang ZL, Hu XH, Wu XH.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep 10; 40(5):817-20, 825. PubMed ID: 19950590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.